1. Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15

   • Marty Chaplin
   • Rebecca Bresnahan
   • Pinki Munot

   Review Article Open access 20 September 2023 Pages: 863 - 875

2. Characteristics and Quality Appraisal of the Economic Evaluations Done in Ethiopia: A Systematic Review

   • Bereket Bahiru Tefera
   • Desalegn Getnet Demsie
   • Zewdu Yilma

   Systematic Review Open access 25 August 2023 Pages: 877 - 886

   

3. Cost-Effectiveness of Non-pharmacological Interventions for Mild Cognitive Impairment and Dementia: A Systematic Review of Economic Evaluations and a Review of Reviews

   • Gillian Eaglestone
   • Evdoxia Gkaintatzi
   • Paul McCrone

   Systematic Review Open access 25 September 2023 Pages: 887 - 914

   

4. Trade-Offs between Vaccine Effectiveness and Vaccine Safety: Personal versus Policy Decisions

   • Semra Ozdemir
   • Sean Ng
   • Eric Andrew Finkelstein

   Original Research Article Open access 11 October 2023 Pages: 915 - 926

   

5. Hospital Resource Utilization and Costs in Patients with Heart Failure in France

   • Frank Chemouni
   • Tiffany Chihiro Nishikawa
   • Deborah Ittah

   Original Research Article Open access 15 September 2023 Pages: 927 - 940

   

6. Retrospective Comparison of Survival Projections for CAR T-Cell Therapies in Large B-Cell Lymphoma

   • Elisabeth F. P. Peterse
   • Elisabeth J. M. Verburg-Baltussen
   • Sven L. Klijn

   Original Research Article Open access 31 August 2023 Pages: 941 - 950

   

7. Budget Impact Analysis of Risperidone Use and Adverse Event Monitoring in Autism Spectrum Disorder in Brazil: Assessment of Theoretical Versus Real Data

   • Luis Phillipe Nagem Lopes
   • Alexander Itria
   • Luciane Cruz Lopes

   Original Research Article Open access 14 September 2023 Pages: 951 - 961

8. The EQ-5D-3L Valuation Study in Pakistan

   • Madeeha Malik
   • Ning Yan Gu
   • Fredrick Dermawan Purba

   Original Research Article Open access 13 September 2023 Pages: 963 - 974

   

9. Cost-Effectiveness of Recombinant Zoster Vaccine for the Prevention of Herpes Zoster in Hematopoietic Stem Cell Transplant Recipients and Other Immunocompromised Adults in the United States

   • Ahmed Salem
   • Elizabeth M. La
   • Christopher F. Carpenter

   Original Research Article Open access 02 November 2023 Pages: 975 - 985

   

10. Estimating Cumulative Health Care Costs of Childhood and Adolescence Autism Spectrum Disorder in Ontario, Canada: A Population-Based Incident Cohort Study

    • Claire de Oliveira
    • Bryan Tanner

    Original Research Article Open access 27 September 2023 Pages: 987 - 995

11. Real-World Cost Effectiveness of a Policy of KRAS Testing to Inform Cetuximab or Panitumumab for Third-Line Therapy of Metastatic Colorectal Cancer in British Columbia, Canada

    • Reka E. Pataky
    • Stirling Bryan
    • Dean A. Regier

    Original Research Article Open access 11 October 2023 Pages: 997 - 1006

    

12. Model and Empirical Data-Based Cost-Utility Studies of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Protocol of a Systematic Review on Methodology and Quality

    • L. A. de Jong
    • X. Li
    • T. L. Feenstra

    Protocol Open access 22 August 2023 Pages: 1007 - 1013

13. Correction: Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15

    • Marty Chaplin
    • Rebecca Bresnahan
    • Pinki Munot

    Correction Open access 05 December 2023 Pages: 1015 - 1015